Nouscom Raises €67.5 million ($72 million) in
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its...
Source: globenewswire.com
📰 Andera Acto News
Andera Acto News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andera Acto. Real-time updates on events, politics, business and more.
Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of...
Source: businessinsider.com
Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic
Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001, targeting
Source: finanznachrichten.de
EQS-News: Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases
EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases 15.05.2023
Source: finanznachrichten.de
Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline
New investors, Andera Partners and Earlybird Venture Capital, join existing investor, Pureos Bioventures raising an additional EUR 22.75 million Funds will be used to advance clinical
Source: finanznachrichten.de
EQS-News: Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics
EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics 18.04.2023 / 09:15 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE A...
Source: boersennews.de
EQS-News: Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®
EQS-News: Andera Partners / Key word(s): Financing Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® 13.04.2023 / 12:45 CET/CEST The issuer
Source: finanznachrichten.de
FIRE1 Raises $25 Million to Revolutionize Heart Failure Home Monitoring
FIRE1, today announced the close of a $25 million financing round led by new investors Andera Partners and Novo Holdings, with participation and ongoing support from existing investors Gilde Healthcare
Source: finanznachrichten.de
EQS-News: Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros
EQS-News: Andera Partners / Key word(s): Funds Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros 16.02.2023 / 09:00 CET/CEST The issuer is solely responsible for the content of this announceme...
Source: boersennews.de
EQS-News: Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches
EQS-News: Andera Partners / Key word(s): Financing Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches 26.01.2023 / 13:10 CET/CEST The issuer is solely responsible for th...
Source: boersennews.de